List of Clarinex D 24 Hour drug patents

Clarinex D 24 Hour is owned by Merck Sharp Dohme.

Clarinex D 24 Hour contains Desloratadine; Pseudoephedrine Sulfate.

Clarinex D 24 Hour has a total of 3 drug patents out of which 3 drug patents have expired.

Expired drug patents of Clarinex D 24 Hour are:

  • US6979463
  • US7820199
  • US7820199*PED

Clarinex D 24 Hour was authorised for market use on 03 March, 2005.

Clarinex D 24 Hour is available in tablet, extended release;oral dosage forms.

The generics of Clarinex D 24 Hour are possible to be released after 28 September, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6979463 MERCK SHARP DOHME Stable extended release oral dosage composition
Mar, 2022

(10 months ago)

US7820199 MERCK SHARP DOHME Stable extended release oral dosage composition
Mar, 2022

(10 months ago)

US7820199

(Pediatric)

MERCK SHARP DOHME Stable extended release oral dosage composition
Sep, 2022

(4 months ago)

Drugs and Companies using DESLORATADINE; PSEUDOEPHEDRINE SULFATE ingredient

Market Authorisation Date: 03 March, 2005

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in